Managing : elimination challenges.
作者信息
Rahimi Farid, Talebi Bezmin Abadi Amin
机构信息
Research School of Biology, The Australian National University, Canberra, ACT, Australia.
Department of Bacteriology, Faculty of Medical Sciences, Tarbiat Modares University, Room 107, First Floor, Tehran 14115-111, Iran.
出版信息
Therap Adv Gastroenterol. 2025 Apr 29;18:17562848251336293. doi: 10.1177/17562848251336293. eCollection 2025.
Abstract
摘要
相似文献
1
Managing : elimination challenges.管理：消除挑战。
Therap Adv Gastroenterol. 2025 Apr 29;18:17562848251336293. doi: 10.1177/17562848251336293. eCollection 2025.
2
Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.不同质子泵抑制剂、CYP2C19基因型差异及抗生素耐药性对质子泵抑制剂、阿莫西林和克拉霉素1周方案根除幽门螺杆菌感染率的影响
Aliment Pharmacol Ther. 2003 Jan;17(2):259-64. doi: 10.1046/j.1365-2036.2003.01406.x.
3
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.基于质子泵抑制剂的1周三联疗法治疗失败后幽门螺杆菌对抗生素继发耐药的发生率：一项前瞻性研究
Dig Liver Dis. 2000 Nov;32(8):667-72. doi: 10.1016/s1590-8658(00)80327-8.
4
Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.马斯特里赫特II治疗方案及不同质子泵抑制剂根除幽门螺杆菌的疗效
World J Gastroenterol. 2004 Jun 1;10(11):1656-8. doi: 10.3748/wjg.v10.i11.1656.
5
Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.基于 vonoprazan 的三联疗法与基于药敏的质子泵抑制剂三联疗法根除幽门螺杆菌的非劣效性研究。
Ann Clin Microbiol Antimicrob. 2018 Jun 28;17(1):29. doi: 10.1186/s12941-018-0281-x.
6
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?基于左氧氟沙星或克拉霉素的四联疗法：在两种抗生素耐药率都很高的国家，作为根除幽门螺杆菌的一线治疗，哪种是最佳替代方案？
BMC Gastroenterol. 2017 Feb 15;17(1):31. doi: 10.1186/s12876-017-0589-6.
7
Development and validation of next-generation sequencing panel for personalized eradication treatment targeting multiple species.开发和验证针对多种物种的个体化根除治疗的下一代测序 panel
Front Cell Infect Microbiol. 2024 Aug 29;14:1379790. doi: 10.3389/fcimb.2024.1379790. eCollection 2024.
8
Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.10 天高剂量质子泵抑制剂三联疗法与序贯疗法根除幽门螺杆菌的比较。
J Gastroenterol Hepatol. 2018 Nov;33(11):1822-1828. doi: 10.1111/jgh.14292. Epub 2018 Jun 27.
9
Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori.系统评价与荟萃分析：强效酸抑制剂——沃诺拉赞优于质子泵抑制剂，可根除克拉霉素耐药的幽门螺杆菌菌株。
Helicobacter. 2018 Aug;23(4):e12495. doi: 10.1111/hel.12495. Epub 2018 Jun 6.
10
Helicobacter pylori eradication in Mexico with a levofloxacin-based scheme versus standard triple therapy: Results from an open-label, randomized, noninferiority phase iiib trial.墨西哥采用基于左氧氟沙星的方案与标准三联疗法根除幽门螺杆菌：一项开放标签、随机、非劣效性 IIIb 期试验的结果
Rev Gastroenterol Mex (Engl Ed). 2019 Jul-Sep;84(3):274-283. doi: 10.1016/j.rgmx.2018.04.005. Epub 2018 Jul 27.
本文引用的文献
1
40 years after the discovery of Helicobacter pylori: towards elimination of H pylori for gastric cancer prevention.幽门螺杆菌发现40年后：迈向消除幽门螺杆菌以预防胃癌
Lancet. 2024 Jun 15;403(10444):2570-2572. doi: 10.1016/S0140-6736(24)01171-1.
2
Management of infection.感染的管理
JGH Open. 2022 Nov 21;7(1):3-15. doi: 10.1002/jgh3.12843. eCollection 2023 Jan.
3
Diagnosis and Treatment of Infection.感染的诊断与治疗
Annu Rev Med. 2022 Jan 27;73:183-195. doi: 10.1146/annurev-med-042220-020814.
4
Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why.幽门螺杆菌的药敏试验现已广泛可用：何时、如何以及为何进行。
Am J Gastroenterol. 2022 Apr 1;117(4):524-528. doi: 10.14309/ajg.0000000000001659.
5
Screening and eradication of for gastric cancer prevention: the Taipei global consensus.胃癌预防的筛查和根除：台北全球共识。
Gut. 2020 Dec;69(12):2093-2112. doi: 10.1136/gutjnl-2020-322368. Epub 2020 Oct 1.
6
Global whole family based- eradication strategy to prevent its related diseases and gastric cancer.全球范围内以家庭为基础的根除策略，以预防其相关疾病和胃癌。
World J Gastroenterol. 2020 Mar 14;26(10):995-1004. doi: 10.3748/wjg.v26.i10.995.
7
Neglected tropical diseases: elimination and eradication.被忽视的热带病：消除和消灭。
Clin Med (Lond). 2019 Mar;19(2):157-160. doi: 10.7861/clinmedicine.19-2-157.
8
Helicobacter pylori Infection: New Facts in Clinical Management.幽门螺杆菌感染：临床管理中的新情况
Curr Treat Options Gastroenterol. 2018 Dec;16(4):605-615. doi: 10.1007/s11938-018-0209-8.
9
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.全球幽门螺杆菌感染率：系统评价和荟萃分析。
Gastroenterology. 2017 Aug;153(2):420-429. doi: 10.1053/j.gastro.2017.04.022. Epub 2017 Apr 27.
10
Six challenges in the eradication of infectious diseases.根除传染病面临的六大挑战。
Epidemics. 2015 Mar;10:97-101. doi: 10.1016/j.epidem.2014.12.001. Epub 2014 Dec 12.
Zotero 插件